About Norrlands universitetssjukhus; Onkologkliniken
University Hospital of Umeå, in Swedish Norrlands universitetssjukhus, is the major hospital in northern Sweden, situated in Umeå. The hospital employs 5,600 people.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
PepTonic Medical AB
2
Pfizer
1
Clinical Trials at Norrlands universitetssjukhus; Onkologkliniken
During the past decade, Norrlands universitetssjukhus; Onkologkliniken conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on
average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
A Study of Trastuzumab Emtansine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer Who Have Received Prior Anti-HER2 And Chemotherapy-based Treatment
Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms
2016-05-03
2017-05-03
Completed
202
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Norrlands universitetssjukhus; Onkologkliniken"
#1 collaborator was "A+ Science AB" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Norrlands universitetssjukhus; Onkologkliniken
According to Clinical.Site data, the most researched conditions in "Norrlands universitetssjukhus; Onkologkliniken" are
"Atrophy" (1 trials), "Basal Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Kidney Neoplasms" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Norrlands universitetssjukhus; Onkologkliniken" in a lesser frequency.
Clinical Trials Intervention Types at Norrlands universitetssjukhus; Onkologkliniken
Most popular intervention types in "Norrlands universitetssjukhus; Onkologkliniken" are "Drug" (7 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Axitinib (AG-013736)" (1 trials), "Bevacizumab" (1 trials), "Oxytocin" (1 trials) and "Oxytocin 400 IU vaginal gel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Norrlands universitetssjukhus; Onkologkliniken
The vast majority of trials in "Norrlands universitetssjukhus; Onkologkliniken" are
5 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Norrlands universitetssjukhus; Onkologkliniken
Currently, there are NaN active trials in "Norrlands universitetssjukhus; Onkologkliniken".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Norrlands universitetssjukhus; Onkologkliniken,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Norrlands universitetssjukhus; Onkologkliniken, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".